Silence Therapeutics's total assets for Q1 2026 were £115.12M, a decrease of -12.42% from the previous quarter. SLN total liabilities were £65.72M for the fiscal quarter, a -4.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.